Nilsine Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Sell |
2,544
-8,790
| -78% | -$3.56M | 0.1% | 196 |
|
|
2025
Q1 | $5.64M | Buy |
11,334
+669
| +6% | +$333K | 0.62% | 32 |
|
|
2024
Q4 | $5.55M | Buy |
10,665
+473
| +5% | +$246K | 0.59% | 34 |
|
|
2024
Q3 | $6.3M | Buy |
10,192
+29
| +0.3% | +$17.9K | 0.82% | 27 |
|
|
2024
Q2 | $5.62M | Buy |
10,163
+268
| +3% | +$148K | 0.75% | 31 |
|
|
2024
Q1 | $5.75M | Buy |
9,895
+265
| +3% | +$154K | 0.79% | 29 |
|
|
2023
Q4 | $5.11M | Sell |
9,630
-906
| -9% | -$481K | 0.79% | 37 |
|
|
2023
Q3 | $5.33M | Buy |
10,536
+806
| +8% | +$408K | 0.81% | 31 |
|
|
2023
Q2 | $5.08M | Sell |
9,730
-111
| -1% | -$57.9K | 0.75% | 31 |
|
|
2023
Q1 | $5.67M | Buy |
+9,841
| New | +$5.67M | 0.89% | 23 |
|